Direct reductions in acute inotropy is thought to be mediated by GPCR43 [24], with more chronic changes mediated by SCFA-mediated downregulation of Egr1—a cardiovascular regulator gene involved in cardiac hypertrophy [11]. The gene discussed is FFAR2; the disease is cardiac hypertrophy.